Echinacoside

Echinacoside is a phenylethanoid glycoside primarily found in Cistanche species that serves as a key bioactive compound in traditional Chinese medicine. This compound demonstrates neuroprotective effects through antioxidant mechanisms and modulation of neuroinflammatory pathways.

Origin & History

Echinacoside is a natural phenylethanoid glycoside primarily extracted from Cistanche tubulosa (Cistanche Herba), a holoparasitic desert plant used in traditional Chinese medicine. It features a complex triglycoside structure with rhamnosyl, caffeoyl, and glucosyl components, and is biosynthesized through sequential enzymatic processes starting from L-tyrosine.

Historical & Cultural Context

Echinacoside is a representative compound in Cistanche Herba (Herba Cistanches) from traditional Chinese medicine, where it has been valued for neuroprotective properties. The traditional use is now challenged by wild resource scarcity of the source plant.

Health Benefits

• Neuroprotective effects - attributed to echinacoside in traditional use contexts, though human clinical evidence not provided in available research
• Traditional medicinal effects - as a key bioactive compound in Cistanche Herba used in TCM, though specific mechanisms remain uncharacterized
• Note: No human clinical trials documenting health benefits are available in the provided research
• Therapeutic applications remain based on traditional use rather than modern clinical evidence
• Further human studies needed to validate traditional claims

How It Works

Echinacoside exerts neuroprotective effects by scavenging reactive oxygen species and reducing oxidative stress in neural tissues. The compound modulates inflammatory pathways by inhibiting pro-inflammatory cytokine production and activation of microglial cells. It may also influence neurotransmitter systems and promote neuronal survival through anti-apoptotic mechanisms.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses for echinacoside are available in the current research. The existing literature focuses primarily on biosynthesis pathways, plant extraction methods, and in vitro characterization rather than human therapeutic applications.

Clinical Summary

Current research on echinacoside consists primarily of preclinical studies and traditional use observations rather than robust human clinical trials. Laboratory studies have demonstrated antioxidant and neuroprotective properties in cell culture and animal models. The compound's effects are primarily documented through its presence in Cistanche herba preparations used in traditional Chinese medicine. Human clinical evidence remains limited, with most research focusing on traditional applications rather than controlled clinical interventions.

Nutritional Profile

Echinacoside is a purified phenylethanoid glycoside compound (molecular formula: C35H46O20, molecular weight: 786.72 g/mol), not a whole food ingredient, so conventional macronutrient/micronutrient profiling does not apply. As an isolated bioactive compound, it contains no meaningful protein, fat, fiber, or caloric content in supplemental form. Primary structural components include a caffeoyl moiety, a rhamnose sugar unit, glucose residues, and a hydroxytyrosol aglycone core, which collectively contribute to its antioxidant activity. In its natural source plant Cistanche tubulosa/Cistanche deserticola (Cistanche Herba), echinacoside concentrations typically range from 0.5% to 3.5% dry weight depending on species, plant part, and growing conditions, with stems generally yielding higher concentrations than other plant parts. Standardized Cistanche extracts are commonly standardized to contain 20–40% echinacoside by weight. As a phenylethanoid glycoside, oral bioavailability is moderately limited due to intestinal hydrolysis and first-pass metabolism; gut microbiota partially cleave glycosidic bonds to release hydroxytyrosol and caffeic acid metabolites, which may contribute to downstream biological activity. Absorption studies in rodent models suggest peak plasma concentrations occur within 1–2 hours post-ingestion, with rapid hepatic metabolism. No standardized human pharmacokinetic data is currently established in published clinical literature.

Preparation & Dosage

No clinically studied dosage ranges have been established for echinacoside in any form (extract, powder, or standardized preparations). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Acteoside, salidroside, tyrosol, caffeic acid derivatives, other phenylethanoid glycosides

Safety & Interactions

Safety data for isolated echinacoside supplementation is limited due to lack of extensive human clinical trials. Traditional use of Cistanche preparations containing echinacoside suggests general tolerability, though specific adverse effects have not been systematically studied. Potential interactions with medications metabolized by liver enzymes remain uncharacterized. Pregnant and breastfeeding women should avoid supplementation due to insufficient safety data.